10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology
Pharmacoepidemiology and Drug Safety · 2025
DOI: 10.1002/pds.70203 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Kenneth K C Man und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK. Hauptthemen laut MEDLINE: Pharmacoepidemiology, Databases, Factual, Research Design. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 Research and Innovation Programme.
Abstract (Originalsprache)
Background
Multi‐national/database pharmacoepidemiological studies are increasingly used to address questions that require pooled evidence across populations but introduce challenges in design, harmonization, and analysis.
Objective
To share 10 practical considerations and common pitfalls in planning, executing, and reporting multi‐national/database studies, with strategies to mitigate them. Approach Practical guidance article synthesizing experience from multi‐national/database projects and literature‐based exemplars; no original data collection.
Results
We summarize ten considerations spanning: protocol development; follow‐up time and eligibility assessment; data harmonization (including thorough metadata and master mapping tables); feasibility checks within each source; statistical model diagnostics; and transparent reporting. We illustrate how local clinical practices, coding systems, and reimbursement policies can shape outcomes and interpretation, and we emphasize the need for proactive, consistent communication among collaborators to ensure aligned implementation.
Conclusion
Multi‐national/database studies are complex but feasible with structured planning, clear communication, and proactive problem‐solving. Adopting the outlined practices can reduce avoidable heterogeneity and improve the robustness and interpretability of findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.
- Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
ORCID-Profile: Kenneth K C Man, Anton Pottegård
Förderung
- European Union's Horizon 2020 Research and Innovation Programme
Zitieren
APA
Man, K. K. C., & Pottegård, A. (2025). 10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70203
Vancouver
Man KKC, Pottegård A. 10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70203
BibTeX
@article{Man2025,
author = {Man, Kenneth K C and Pottegård, Anton},
title = {10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
doi = {10.1002/pds.70203}
}
EUVIMED